Sponsor:
Replimune Inc.
Code:
NCT06264180
Conditions
Advanced Melanoma
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Vusolimogene Oderparepvec
Nivolumab
Nivolumab + Relatlimab
Pembrolizumab
Single-agent chemotherapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations